drugset / Trial / NCT07292025
Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 1 trial to evaluate the safety and efficacy of JTM201 compared with 'Botox® Inj.' in subjects with post-stroke upper limb spasticity
Timeline
- Start
- 2023-06-29
- Primary completion
- 2024-04-22
- Completion
- 2024-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 100 unknown | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 360 unknown | Intramuscular |
| Subject | JTM201 | Unknown | 360 unknown | Intramuscular |